USING CONTINUOUS QUALITY IMPROVEMENT METHODOLOGIES TO REDUCE CLOSTRIDIUM DIFFICILE TESTING DELAYS

Sarah Baron, MD, MS1, Belinda Ostrowsky, MD. MPH, Michael Levi, Sc.D., ABMM, Wendy Szymczak, PhD, D(ABMM), Carol Sheridan, RN, MSN, OCN, BMTCN2, Takahiro Tanaka, MHA, Jennica Meehan, M.S., William Southern, MD, MS, SFHM2, 1Montefiore Medical Center, Bronx, NY; 2Bronx, NY

Meeting: Hospital Medicine 2019, March 24-27, National Harbor, Md.

Abstract number: 266

Categories: Hospital Medicine 2019, Quality Improvement, Research

Keywords: , , , ,

Background: Timely Clostridium difficile Infection (CDI) testing is challenging but is important for faster and appropriate isolation and treatment of patients. Few studies have specifically addressed effective methods to hasten CDI testing without relying on PCR. We sought to use Quality Improvement methodologies including the Plan-Do-Study-Act (PDSA) Cycle and Control Charts to reduce CDI testing delays.

Methods: This Quality Improvement and Infection Control project was conducted in a large, academic medical center in the Bronx. As part of a larger effort to decrease hospital onset CDI and improve appropriate CDI testing, a multidisciplinary team of nurses, front-line doctors, healthcare epidemiologists, quality improvement experts, Infection Preventionists, Microbiologists, and systems engineers met weekly to reduce the CDI Turn Around Time (CDI-TAT) defined as time from order to result of a CDI test. Plan-Do-Study-Act (PDSA) cycles targeted small tests of change at one of three domains: collection of the specimen, transportation of the specimen, and analysis of the specimen in the laboratory. 5 PDSA cycles were performed. Results were analyzed by a comparison of means using t-tests as well as a Quality Improvement assessment examining for 8 points in a row below the mean on a control chart, which is routinely used to indicate special cause variation, the equivalent of statistical significance.

Results: On examination of the Control Chart (Figure 1), 2 of the 5 PDSA cycles were successful in decreasing CDI-TAT, both of which targeted analysis of the specimen. The mean CDI-TAT decreased from 34.8 to 28.7 hours (p<0.001) after the second PDSA and decreased further to 23.5 hours after the final PDSA cycle (p<0.001). These gains were sustained through the following 6 months without additional resources. Furthermore, these gains in timing allowed for additional interventions targeted at reducing hospital onset CDI, the outcome measure. An unexpected benefit of the changes was a more efficient and therefore acceptable testing algorithm for the laboratory.

Conclusions: Using Quality Improvement tools, out multidisciplinary team significantly reduced mean CDI-TAT and sustained the reduction. The flexibility of Quality Improvement tools makes them ideal for Hospital Acquired Infection reduction efforts in addition to improvement of other quality metrics.

IMAGE 1: C. difficile Testing Turn Around Time Control Chart

To cite this abstract:

Baron, S; Ostrowsky, B; Levi, M; Szymczak, WA; Sheridan, CA; Tanaka, T; Meehan, J; Southern, W. USING CONTINUOUS QUALITY IMPROVEMENT METHODOLOGIES TO REDUCE CLOSTRIDIUM DIFFICILE TESTING DELAYS. Abstract published at Hospital Medicine 2019, March 24-27, National Harbor, Md. Abstract 266. https://www.shmabstracts.com/abstract/using-continuous-quality-improvement-methodologies-to-reduce-clostridium-difficile-testing-delays/. Accessed January 19, 2020.

« Back to Hospital Medicine 2019, March 24-27, National Harbor, Md.